Top

Published in:

01-02-2013 | Urogenital

Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma

Authors: Andrew B. Rosenkrantz, Aarti Sekhar, Elizabeth M. Genega, Jonathan Melamed, James S. Babb, Amish D. Patel, Andy Lo, Robert M. Najarian, Muneeb Ahmed, Ivan Pedrosa

Published in: European Radiology | Issue 2/2013

Abstract

Objective

To evaluate the prognostic implications of the MRI appearance and pathological features of papillary renal cell carcinoma (pRCC).

Methods

A total of 128 pRCC in 115 patients who underwent preoperative MRI were characterised in terms of pathological type (type 1 vs. type 2), MRI appearance (focal vs. infiltrative) and additional MRI features. Patients were classified on the basis of the presence or absence of metastatic disease.

Results

There were 65 focal type 1, 54 focal type 2 and 9 infiltrative pRCC. All infiltrative pRCC were of histopathological type 2. Renal vein thrombus was present in 89 % of infiltrative pRCC and no cases of focal pRCC. Metastatic disease was observed in 3.7 % of focal type 1, 7.5 % of focal type 2 and 75.0 % of infiltrative type 2 pRCC. Infiltrative MRI appearance was a significant predictor of metastatic disease, independent of pathological type, size and T stage (P ≤ 0.020). Among focal pRCC on MRI, pathological type 2 was not a significant predictor of metastatic disease (P = 0.648). No combination of features achieved significantly greater accuracy for predicting metastatic disease than renal vein thrombus alone (P > 0.5).

Conclusion

Infiltrative MRI appearance and renal vein thrombus identify a subset of pathological type 2 pRCC at a significantly increased risk of metastatic disease.

Key Points

• Magnetic resonance imaging (MRI) offers new preoperative insights into renal cell carcinoma (RCC).

• Certain MRI features are associated with metastatic papillary RCC.

• Metastases seem more common given an infiltrative appearance and renal vein thrombus.

Amin MB, Tamboli P, Javidan J et al (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26:281–291PubMedCrossRef

Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624PubMedCrossRef

Leroy X, Zini L, Leteurtre E et al (2002) Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 15:1126–1130. doi:10.1097/01.MP.0000036346.88874.25 PubMedCrossRef

Teloken PE, Thompson RH, Tickoo SK et al (2009) Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol 182:2132–2136PubMedCrossRef

Pignot G, Elie C, Conquy S et al (2007) Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 69:230–235PubMedCrossRef

Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG (2008) Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112:1480–1488PubMedCrossRef

Allory Y, Ouazana D, Boucher E, Thiounn N, Vieillefond A (2003) Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Virchows Arch 442:336–342PubMed

Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544PubMed

Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM (2001) Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 32:590–595PubMedCrossRef

10.

Yamashita S, Ioritani N, Oikawa K, Aizawa M, Endoh M, Arai Y (2007) Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis. Int J Urol 14:679–683PubMedCrossRef

11.

Yang XJ, Tan MH, Kim HL et al (2005) A molecular classification of papillary renal cell carcinoma. Cancer Res 65:5628–5637PubMedCrossRef

12.

Ku JH, Moon KC, Kwak C, Kim HH, Lee SE (2009) Is there a role of the histologic subtypes of papillary renal cell carcinoma as a prognostic factor? Jpn J Clin Oncol 39:664–670PubMedCrossRef

13.

Gontero P, Ceratti G, Guglielmetti S et al (2008) Prognostic factors in a prospective series of papillary renal cell carcinoma. BJU Int 102:697–702PubMedCrossRef

14.

Schrader AJ, Rauer-Bruening S, Olbert PJ et al (2009) Incidence and long-term prognosis of papillary renal cell carcinoma. J Cancer Res Clin Oncol 135:799–805PubMedCrossRef

15.

Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll PR (1991) Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 178:803–809PubMed

16.

Pretorius ES, Siegelman ES, Ramchandani P, Cangiano T, Banner MP (1999) Renal neoplasms amenable to partial nephrectomy: MR imaging. Radiology 212:28–34PubMed

17.

Ergen FB, Hussain HK, Caoili EM et al (2004) MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol 182:217–225PubMed

18.

Israel GM, Hindman N, Bosniak MA (2004) Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231:365–371PubMedCrossRef

19.

Sun MR, Ngo L, Genega EM et al (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250:793–802PubMedCrossRef

20.

Pedrosa I, Chou MT, Ngo L et al (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18:365–375PubMedCrossRef

21.

Pedrosa I, Sun MR, Spencer M et al (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics 28:985–1003PubMedCrossRef

22.

Yamada T, Endo M, Tsuboi M et al (2008) Differentiation of pathologic subtypes of papillary renal cell carcinoma on CT. AJR Am J Roentgenol 191:1559–1563PubMedCrossRef

23.

Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195:W421–W427PubMedCrossRef

24.

Lang H, Lindner V, de Fromont M et al (2005) Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: assessment of 241 patients with > 15-year follow-up. Cancer 103:625–629PubMedCrossRef

25.

Klatte T, Anterasian C, Said JW et al (2010) Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma. J Urol 183:2143–2147PubMedCrossRef

26.

Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B (2006) Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 30:1091–1096PubMedCrossRef

Title: Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma
Authors: Andrew B. Rosenkrantz
Aarti Sekhar
Elizabeth M. Genega
Jonathan Melamed
James S. Babb
Amish D. Patel
Andy Lo
Robert M. Najarian
Muneeb Ahmed
Ivan Pedrosa
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: European Radiology / Issue 2/2013
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-012-2631-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma

Abstract

Objective

Methods

Results

Conclusion

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Key Points

Please log in to get access to this content

Other articles of this Issue 2/2013

In vitro stent lumen visualisation of various common and newly developed femoral artery stents using MR angiography at 1.5 and 3 tesla

“Reply to letter to the editor re: diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis”

The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55)

Letter to the editor re: “Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis”—unfair study selection in meta-analysis

Measurement of quantifiable parameters by time-density curves in the elastase-induced aneurysm model: first results in the comparison of a flow diverter and a conventional aneurysm stent

Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers